Chapter 3: Data Interpretation Flashcards
1
Q
Causes of anaemia (categorised by MCV)
A
Red blood cells:
- Microcytic (low MCV) = iron deficiency anaemia, thalassaemia, sideroblastic anaemia.
- Normocytic (normal MCV) = anaemia of chronic disease, acute blood loss, haemolytic anaemia, renal failure (chronic).
-
Macrocytic (high MCV) = B12/folate deficiency (megaloblastic anaemia), excess alcohol, liver disease (including non-alcoholic causes), hypothyroidism, “M” haematological causes (myeloproliferative, myelodysplastic, multiple myeloma).
- B12 deficiency includes pernicious anaemia.
2
Q
Causes of neutrophilia
A
Neutrophilia (high) :
- bacterial infection
- tissue damage (inflammation/infarct/malignancy)
- *steroids*.
3
Q
Causes of Neutropenia
A
Neutropenia (low neutrophils)
- viral infection
- chemotherapy/radiotherapy (may become neutropenic in response to infection, neutropenic sepsis)
- If neutropenic sepsis, must give urgent IV broad-spectrum antibiotics (hospital-specific).
- clozapine (antipsychotic)
- carbimazole (antithyroid).
4
Q
Causes of lymphocytosis
A
Lymphocytosis (high lymphocyts)
- viral infection
- lymphoma
- CLL.
5
Q
Causes of Thrombocytopenia
A
Thrombocytopenia (low platelets)
- reduced production
- viral infection
- drugs especially penicillamine in RA
- myelodysplasia, myelofibrosis, myeloma
- increased destruction
- heparin
- hypersplenism
- DIC
- ITP
- HUS/TTP
6
Q
Causes of thombocytosis
A
Thrombocytosis (high platelets)
- reactive
- bleeding
- tissue damage e.g. infection/inflammation/malignancy
- post-splenectomy
- primary
- myeloproliferative disorders
7
Q
Causes of hyponatraemia
Na+ 135-145 mmol/L
A
Hyponatraemia: assess fluid status first.
- Hypovolaemic
- fluid loss (D&V)
- Addison’s
- any diuretic.
- Euvolaemic
- SIADH
- small cell lung tumours, _i_nfection, abscess, drugs (carbamazepine + antipsychotics), head injury.
- psychogenic polydipsia
- hypothyroidism.
- SIADH
- Hypervolaemic
- heart failure
- renal failure
- liver failure (hypoalbuminaemia)
- nutritional failure (hypoalbuminaemia)
- thyroid failure (hypothyroidism – can be euvolaemic too).
8
Q
Causes of SIADH
A
SIADH
- small cell lung tumours
- infection
- abscess
- drugs (carbamazepine + antipsychotics)
- head injury.
9
Q
Causes of Hypernatraemia
A
Hypernatraemia: Causes all begin with “D”…
- Dehydration.
- Drips i.e. too much IV saline.
- Drugs e.g. effervescent tablet preparations or IV preparations with high Na+ content.
- Diabetes insipidus – opposite of SIADH.
10
Q
Causes of Hypokalaemia (3.5-5mmol/L)
A
Hypokalaemia: DIRE
- drugs (loop + thiazide diuretics)
- inadequate intake or intestinal loss (D&V)
- renal tubular acidosis
- endocrine (Cushing’s + Conn’s syndrome).
11
Q
Causes of Hyperkalaemia (3.5-5mmol/L)
A
Hyperkalaemia: DREAD
- drugs (K+-sparing diuretics + ACE-i) [& ARBS]
- renal failure
- endocrine (Addison’s disease)
- artefact (clotted sample)
- DKA (when insulin given to treat DKA, K+ drops so needs monitoring + replacement).
12
Q
Link between urea and Hb
A
Ur rise = AKI or upper GI haemorrhage
Hb broken down by gastric acid into Ur, then absorbed into blood
In an upper GI H’gge you may fine a low Hb, Ur rise.
nb isolated urea rise (without Creatinine rise may be seen in pre-renal causes of renal failure e.g. DEHYDRATION)
13
Q
Causes of pre-renal AKI
A
Pre-renal = U rise > C rise (U x 10 > C).
- Dehydration (or if severe, shock) e.g. sepsis, blood loss.
- Renal artery stenosis (often triggered by drugs e.g. ACEi or NSAIDs; renal hypoperfusion)
14
Q
Causes of renal AKI
A
Intrinsic = U rise < C rise, no bladder or hydronephrosis.
INTRINSIC
- ischaemic (prerenal AKI → ATN)
- nephrotoxic antibiotics
- gentamicin, vancomycin + tetracyclines
- tablets
- ACE-i, NSAIDs
- radiological contrast
- injury; rhabdomyolsis
- negatively birefringent crystals (gout)
- syndromes; glomerulonephridites
- inflammation; vasculitis
- cholesterol emboli.
15
Q
Causes of post renal AKI
A
Post-renal = U rise < C rise, bladder or hydronephrosis.
- In lumen = stone or sloughed papilla.
- In wall = tumour (renal cell, transitional cell), fibrosis.
- External pressure = benign prostatic hyperplasia, prostate cancer, lymphadenopathy, aneurysm.
16
Q
LFT:
- Markers of hepatocellular injury or cholestasis
- Synthetic function
A
- bilirubin, ALT, AST, ALP.
- Albumin, vit K dependent clotting factors (2,7,9,10) measure PT/INR
17
Q
Causes of raised bilirubin (3 categories)
A
- Bilirubin rise only = pre-hepatic e.g.
- haemolysis
- Gilbert’s syndrome
- Crigler-Najjar syndrome
- Bilirubin + AST/ALT rise = hepatic e.g.
- fatty liver
- hepatitis
- cirrhosis
- Hepatitis + cirrhosis = alcohol, viruses (hepatitis A-E, CMV + EBV), drugs (paracetamol overdose).
- malignancy; 1⁰ or 2⁰
- metabolic; Wilson’s, haemochromatosis
- HF
- Bilirubin + ALP rise = post-hepatic i.e. obstruction…
- In lumen = gallstones, drugs (flucloxacillin, co-amoxiclav, nitrofurantoin, steroids + sulphonylureas).
- In wall = cholangiocarcinoma, PBC, PSC.
- External pressure = pancreatic or gastric cancer, lymph nodes.
18
Q
Causes of raised ALP
A
ALKPHOS
- any fracture
- liver damage (post-hepatic)
- k for kancer
- Paget’s + pregnancy
- hyperparathyroidism
- osteomalacia
- surgery.
19
Q
Thyroid Fynction tests: and Changing levothyroxine!
A
Check TSH (0.5-5mIU/L), and change by smallest increment offered (unless grossly hypo/hyperthyroid).
- <0.5 = decrease dose
- 0.5-5 = nil action
- >5 = increase dose.
20
Q
Abnormal TFTs: Hypothyroidism
A
Primary hypothyroidism = ↓T4 from thyroid so ↑TSH from pituitary = Hashimoto’s, drug-induced.
Secondary hypothyroidism = ↓TSH, so ↓T4 = pituitary tumour or damage.
21
Q
Abnormal TFTs: Hyperthyroidism
A
Primary hyperthyroidism = ↑T4, so ↓TSH = Grave’s, toxic nodular goitre, drug-induced.
Secondary hyperthyroidism = ↑TSH, so ↑T4 = pituitary tumour.
22
Q
Quick review of CXR:
PIPRA + ABCDEFGH
PSA=?pneumonia/pulmonary oedema
A
PIPRA:
- Projection: PA (N, PA if no markings) or AP (can’t comment on heart) – should see from above clavicles to below diaphragm.
- Inspiration: 7th anterior (down-sloping) rib transects diaphragm.
- Penetration: vertebral bodies behind heart.
- Rotation: distance between spinous processes + clavicles equal.
- Artefact: if present.
ABCDEFGH:
- Airways: trachea central – if not, consider collapse (towards) or pneumothorax (away).
- Bone: rib fractures or lytic lesions.
- Cardiac: cardiothoracic ratio <50% on PA film.
- Diaphragm: air under diaphragm – bowel perforation or recent surgery; under L side is gastric bubble (N).
- Edges: costophrenic + cardiophrenic angles sharp or blunt (effusion).
- Fields: white area = effusion (unilateral + solid), pneumonia (unilateral + fluffy), oedema (bilateral + fluffy), fibrosis (bilateral + honeycomb).
- Oedema, ABCDE = alveolar oedema, kerley B lines, cardiomegaly, diversion of blood to upper lobes, effusions.
- Sail sign (triangle shape) behind heart = L lower lobe collapse.
- Gynaecomastia + other soft-tissues.
- Hila.
23
Q
Quick review of ABG
A
- Check inspired oxygen concentration (FiO2):
- Calculate N PaO2 for patient on oxygen: subtract 10 from FiO2, and if PaO2 exceeds this number, then patient not hypoxic.
- E.g. On 60% oxygen with FiO2 of 30kPa actually hypoxic. Accurately done via arterial-alevolar gradient.
- Calculate N PaO2 for patient on oxygen: subtract 10 from FiO2, and if PaO2 exceeds this number, then patient not hypoxic.
- Check for respiratory failure: if PaO2 low or inappropriately N.
- Type 1 = low or N PaCO2 (fast breathing) → heart/lung damage causing SOB.
- Type 2 = high PaCO2 (slow breathing) → ‘blue-bloaters’ of COPD, NM failure or restrictive chest wall abnormalities.
- Check acid-base status:
- Low pH = acidosis; high pH = alkalosis.
- PaCO2 abnormal = respiratory. HCO3 abnormal = metabolic. Both = compensation (fully if pH normal, otherwise partial). Both abnormal in opposite directions = mixed.
24
Q
Causes of the 4 acid base abnormalities
A
Respiratory alkalosis = rapid breathing – disease or anxiety.
Respiratory acidosis = same causes as T2RF. (COPD, blue bloaters, + neuromuscular failure + restrictive chest wall abn)
Metabolic alkalosis = vomiting, diuretics + Conn’s syndrome.
Metabolic acidosis = multiple causes e.g. lactic acidosis, DKA, renal failure, ethanol/methanol/ethylene glycol intoxication → narrow cause by using anion gap.
25
Quick review of ECG interpretation
**Rate**: divide 300 by # of large squares between each QRS complex; N = 60-100bpm.
**Rhythm**: p-waves present before QRS = sinus; PR interval not constant or \>1 square = heart block → 1st degree = constant but \>1 square, 2nd degree type 1 = increasing PR then misses a QRS, 2nd type 2 = 2/3 p waves for every QRS, 3rd/complete = no relationship; no p waves + irregular QRS complexes = AF.
**Axis**: look at direction of I and II. If I +ve and II +ve = N; If I +ve and II –ve = LAD; If I –ve and II +ve = RAD.
**QRS**: width \<3 small squares = N, narrow-complex; \>3 = BBB – WiLLiaM = LBBB, rSR (M shape) in V6, MarRRoW = RBBB, rSR in V1.
**QRS height:** Add largest deflection in V1 to V6; \>3.5 large squares = LVH (Sokolov-Lyon); small complexes throughout = pericardial effusion.
**ST segment**: elevated = infarction (flat + some leads) or pericarditis (convex + all leads); depressed = ischaemia (flat + some leads) or digoxin (down-sloping, all leads).
**T-waves**: height \> 2/3rd QRS height throughout ECG = hyperkalaemia; inversion = N in aVR + I, other leads = old infarction/LVH
26
What criteria would suggest the need for monitoring
name 6 common drugs that require monitoring
Drug with _narrow therapeutic index_; small difference in blood concentration for therapeutic + toxic effects require monitoring
1. digoxin
2. theophylline
3. lithium
4. phenytoin
5. ABx: gentamicin
6. ABx: vancomycin
27
What does drug monitoring entale (2 part)
Monitoring
1. assess clinical state
* response to drug
* evidence of toxicity
2. measure serum drug levels
→ adjust dose/frequency accordingly
28
For what reasons is the dose/freq of a drug altered (4)
_Inadequate response + low serum drug level_ = increase dose – in general by smallest possible increment, especially if 0-order kinetics (e.g. phenytoin).
_Adequate response + N/low serum drug level_ = no change – clinical response more important, as already therapeutic dose!
_Adequate response + high serum drug level_ = decrease dose – if toxicity, then can omit for few days (except **gentamicin**).
* gent: pre-emptive decrease in frequency by 12hrs (e.g. 36 rather than 24hrs)
_Toxicity + any serum drug level_ = (1) stop dose (+ alternative); (2) supportive measures (usually IV fluids); (3) give antidote
29
Common signs of drug toxicity
* Digoxin
* Lithium
* Phenytoin
* Gentamicin
* Vancomycin
* Digoxin
* confusion
* nausea
* visual halos
* arrythmia
* Lithium
* early: tremor
* intermediate: tiredness
* Later: arrhythmias
* seizures
* coma
* renal failure
* diabetes insipidus
* Phenytoin
* gum hypertrophy
* ataxia
* nystagmus
* peripheral neuropathy
* teratogenicity
* Gentamicin
* ototoxicity
* nephrotoxicity
* Vancomycin
* ototoxicity
* nephrotoxicity
30
Gentamicin normal dosing (&2 exceptions)
Gentamicin monitoring: IV aminoglycoside antibiotic used in severe infections.
Doses calculated via weight + renal function.
* Most treated with high-dose regimen of 5-7mg/kg once-daily;
* Renal failure patient recieve divided daily dosing (1mg/kg) 12-hourly
* Endocarditis patients recieve divided daily dosing (1mg/Kg) 8-hourly
*Must monitor as high risk of nephrotoxicity + ototoxicity.*
31
Gentamicin: Normal once daily regime monitoring
*Risk of ototoxicity and nephrotoxicity*
* Measure gentamicin levels at particular times e.g. 6-14h after last gentamicin infusion started.
* Use nomogram (specific to dose). If point on graph falls within 24h area, continue at same dose. If above 24h area, then change dosing:
* If in 36h area, change to 36-hourly dosing.
* If in 48h area, change to 48-hourly dosing.
* If above 48h area, repeat gentamicin level and only re-dose when concentration \<1mg/L.
* Change frequency over dose as need sufficient dose to hit peak to hit minimum inhibitory concentration of organism.
32
Gentamicine: divided daily dosing regimes + monitoring
Divided daily dosing: Nomogram exists, but daily peak and trough levels usually used instead.
* **Peak** (1hr post dose) if outside of normal range (3-5mg/L (endocarditis) 5-10mg/L (all else)) adjust the **dose**
* **Trough** (just before next dose) if outside of normal range (\<1mg/L (endocarditis) \<2mg/L (all else)) adjust the **interval**
33
Management of paracetamol overdose (2)
* Specific = N-acetyl cysteine (NAC) if appropriate.
* *Paracetamol metabolised by liver; relies on glutathione which is quickly depleted so toxic NAPQI accumulates. NAC replenishes it.*
* Supportive = particularly IV fluids.
34
Warfarin Mechanism of action
Inhibits synthesis of vitamin K-dependent clotting factors (**2, 7, 9 + 10**) – prolongs PT from which INR derived.
35
What is INR?
INR = ratio of patient PT to N population.
Normal INR = 1. INR
Only used to monitor warfarin – use PT for liver disease/ DIC
36
Target INRs
Target INR for most = **2.5**
if recurrent thromboembolism while on warfarin or metal replacement heart valves INR = **3.5.**
37
If major bleed on warfarin i.e. causing hypotension or bleeding in confined space (brain or eye):
1. Stop **warfarin**
2. give 5-10mg **IV vitamin K**
3. give **prothrombin complex** (e.g. Beriplex) : this if factors 2,7,9,10. If not avaliable give fresh frozen plasma
38
How to manage over coagulation (in minor bleeding or no bleeding)
If not bleeding, then look at INR to judge next step:
* **INR \<5** = reduce warfarin dose.
* **INR 5-8** = omit 1 or 2 doses of warfarin then reduce dose.
* **INR \>8** = omit warfarin + give *1-5mg oral vitamin K (phytomenadione)*
If ***minor*** bleeding, with **INR \>5**, give ***_IV instead of oral vitamin K._***
* **INR \>5** = stop warfarin + give vit K *_IV instead of oral_*
unexpected bleeding at therapeutic levels - always Ix possibility of underlying cause e.g. renal or GI tract pathology
